Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Discordance in the epithelial cell-dendritic cell MHC class II immunoproteome: implications for Chlamydia vaccine development.

Karunakaran KP, Yu H, Jiang X, Chan QWT, Foster LJ, Johnson RM, Brunham RC.

J Infect Dis. 2019 Oct 10. pii: jiz522. doi: 10.1093/infdis/jiz522. [Epub ahead of print]

PMID:
31599954
2.

Identification of MHC-Bound Peptides from Dendritic Cells Infected with Salmonella enterica Strain SL1344: Implications for a Nontyphoidal Salmonella Vaccine.

Karunakaran KP, Yu H, Jiang X, Chan Q, Goldberg MF, Jenkins MK, Foster LJ, Brunham RC.

J Proteome Res. 2017 Jan 6;16(1):298-306. doi: 10.1021/acs.jproteome.6b00926. Epub 2016 Nov 10.

3.

Using MHC Molecules to Define a Chlamydia T Cell Vaccine.

Karunakaran KP, Yu H, Foster LJ, Brunham RC.

Methods Mol Biol. 2016;1403:419-32. doi: 10.1007/978-1-4939-3387-7_23.

PMID:
27076145
4.

Subunit vaccines for the prevention of mucosal infection with Chlamydia trachomatis.

Yu H, Karunakaran KP, Jiang X, Brunham RC.

Expert Rev Vaccines. 2016 Aug;15(8):977-88. doi: 10.1586/14760584.2016.1161510. Epub 2016 Mar 21. Review.

5.

Bioinformatic Analysis of Chlamydia trachomatis Polymorphic Membrane Proteins PmpE, PmpF, PmpG and PmpH as Potential Vaccine Antigens.

Nunes A, Gomes JP, Karunakaran KP, Brunham RC.

PLoS One. 2015 Jul 1;10(7):e0131695. doi: 10.1371/journal.pone.0131695. eCollection 2015.

6.

Outer membrane proteins preferentially load MHC class II peptides: implications for a Chlamydia trachomatis T cell vaccine.

Karunakaran KP, Yu H, Jiang X, Chan Q, Moon KM, Foster LJ, Brunham RC.

Vaccine. 2015 Apr 27;33(18):2159-66. doi: 10.1016/j.vaccine.2015.02.055. Epub 2015 Mar 1.

7.
8.

PmpG303-311, a protective vaccine epitope that elicits persistent cellular immune responses in Chlamydia muridarum-immune mice.

Johnson RM, Yu H, Kerr MS, Slaven JE, Karunakaran KP, Brunham RC.

Infect Immun. 2012 Jun;80(6):2204-11. doi: 10.1128/IAI.06339-11. Epub 2012 Mar 19.

9.

Chlamydia muridarum T cell antigens and adjuvants that induce protective immunity in mice.

Yu H, Karunakaran KP, Jiang X, Shen C, Andersen P, Brunham RC.

Infect Immun. 2012 Apr;80(4):1510-8. doi: 10.1128/IAI.06338-11. Epub 2012 Jan 30.

10.

Immunization with live and dead Chlamydia muridarum induces different levels of protective immunity in a murine genital tract model: correlation with MHC class II peptide presentation and multifunctional Th1 cells.

Yu H, Karunakaran KP, Kelly I, Shen C, Jiang X, Foster LJ, Brunham RC.

J Immunol. 2011 Mar 15;186(6):3615-21. doi: 10.4049/jimmunol.1002952. Epub 2011 Feb 4.

11.

Human papillomavirus 16 (HPV 16) and HPV 18 antibody responses measured by pseudovirus neutralization and competitive Luminex assays in a two- versus three-dose HPV vaccine trial.

Krajden M, Cook D, Yu A, Chow R, Mei W, McNeil S, Money D, Dionne M, Karunakaran KP, Palefsky JM, Dobson S, Ogilvie G, Petric M.

Clin Vaccine Immunol. 2011 Mar;18(3):418-23. doi: 10.1128/CVI.00489-10. Epub 2011 Jan 19.

12.

Development of a Chlamydia trachomatis T cell Vaccine.

Karunakaran KP, Yu H, Foster LJ, Brunham RC.

Hum Vaccin. 2010 Aug;6(8):676-80. Epub 2010 Aug 1. Review.

14.

Differences in innate immune responses correlate with differences in murine susceptibility to Chlamydia muridarum pulmonary infection.

Jiang X, Shen C, Yu H, Karunakaran KP, Brunham RC.

Immunology. 2010 Apr;129(4):556-66. doi: 10.1111/j.1365-2567.2009.03157.x. Epub 2009 Sep 11.

15.
16.

Severe acute respiratory syndrome vaccine efficacy in ferrets: whole killed virus and adenovirus-vectored vaccines.

See RH, Petric M, Lawrence DJ, Mok CP, Rowe T, Zitzow LA, Karunakaran KP, Voss TG, Brunham RC, Gauldie J, Finlay BB, Roper RL.

J Gen Virol. 2008 Sep;89(Pt 9):2136-46. doi: 10.1099/vir.0.2008/001891-0.

PMID:
18753223
17.

Immunoproteomic discovery of novel T cell antigens from the obligate intracellular pathogen Chlamydia.

Karunakaran KP, Rey-Ladino J, Stoynov N, Berg K, Shen C, Jiang X, Gabel BR, Yu H, Foster LJ, Brunham RC.

J Immunol. 2008 Feb 15;180(4):2459-65.

18.

Effect of a structured educational intervention on explanatory models of relatives of patients with schizophrenia: randomised controlled trial.

Das S, Saravanan B, Karunakaran KP, Manoranjitham S, Ezhilarasu P, Jacob KS.

Br J Psychiatry. 2006 Mar;188:286-7.

PMID:
16507973
19.

Comparative evaluation of two severe acute respiratory syndrome (SARS) vaccine candidates in mice challenged with SARS coronavirus.

See RH, Zakhartchouk AN, Petric M, Lawrence DJ, Mok CP, Hogan RJ, Rowe T, Zitzow LA, Karunakaran KP, Hitt MM, Graham FL, Prevec L, Mahony JB, Sharon C, Auperin TC, Rini JM, Tingle AJ, Scheifele DW, Skowronski DM, Patrick DM, Voss TG, Babiuk LA, Gauldie J, Roper RL, Brunham RC, Finlay BB.

J Gen Virol. 2006 Mar;87(Pt 3):641-50.

PMID:
16476986
20.

Serum antibody response to the heat shock protein 60 of Chlamydia trachomatis in women with developing cervical cancer.

Paavonen J, Karunakaran KP, Noguchi Y, Anttila T, Bloigu A, Dillner J, Hallmans G, Hakulinen T, Jellum E, Koskela P, Lehtinen M, Thoresen S, Lam H, Shen C, Brunham RC.

Am J Obstet Gynecol. 2003 Nov;189(5):1287-92.

PMID:
14634555
21.

Molecular analysis of the multiple GroEL proteins of Chlamydiae.

Karunakaran KP, Noguchi Y, Read TD, Cherkasov A, Kwee J, Shen C, Nelson CC, Brunham RC.

J Bacteriol. 2003 Mar;185(6):1958-66.

22.

Molecular detection and seroepidemiology of the Chlamydia pneumoniae bacteriophage (PhiCpn1).

Karunakaran KP, Blanchard JF, Raudonikiene A, Shen C, Murdin AD, Brunham RC.

J Clin Microbiol. 2002 Nov;40(11):4010-4.

23.

EXPOSURE OF BENIGN TRACHEAL TUMOURS BY TRANSVERSE DIVISION OF THE TRACHEA.

SMITH RA, KARUNAKARAN KP.

Br J Surg. 1965 Apr;52:270-6. No abstract available.

PMID:
14271086

Supplemental Content

Loading ...
Support Center